Global Point of Care/Rapid Diagnostic Market – Analysis and Forecast (2018-2024)

Feb 24, 2020

70 likes | 84 Views

Point of care diagnostic allows diagnoses in the remote setting, home, physicianu2019s office, or in the hospital. The outcomes of diagnosis are rapid, and allow speedy treatment to the patient. The global point of care/rapid diagnostic market is growing at significant rate, due to mounting occurrence of infectious diseases and technological improvements and innovative product launches. Different products contributed to the point of care/rapid diagnostic market size. The market has witnessed high demand for infectious disease testing over the last few years due escalating accessibility and alertness about infectious disease POC testing products. Market Segmentation Insight by Product On the basis of product the market is subdivided into coagulation testing, glucose monitoring, tumor/cancer marker testing, cardiometabolic testing, pregnancy and fertility testing, infectious disease testing, urinalysis testing, drugs-of-abuse testing, cholesterol testing, fecal occult testing, hematology testing and others. Of all products, infectious disease testing segment is expected to grow at fastest rate in the market due to mounting patient population base and escalating accessibility and alertness about infectious disease POC testing products. Insight by Platform On the basis of platform the market is subdivided into lateral flow assays (immunochromatography tests), molecular diagnostics, dipsticks, immunoassays and microfluidics. Mounting progressions in technology, resource-limited locations, and intensifying initiatives of market players for developing POC diagnostics products are some of the factors responsible for the growth of the molecular diagnostics segment. Of all the platforms, the molecular diagnostics is expected to grow at fastest rate in the point of care/rapid diagnostic market. In addition, lateral flow assays accounted the largest share in the market due to mounting occurrence of infectious diseases and budding acceptance of lateral flow POC diagnostics. Insight by Prescription Mode On the basis of prescription mode the market is subdivided into OTC testing and prescription-based testing. Mounting occurrence of lifestyle diseases and the absence of alertness on OTC POCT devices in developing nations are the factors growing the demand of prescription-based testing. Among the all prescription mode, the prescription-based testing accounted largest share in the point of care/rapid diagnostic market. Insight by End User The different end users of the market are research laboratories, professional diagnostic centers, home care and others. Mounting inclination for home and remote monitoring and expanding need for rapid tests among home care users are the factors growing the demand of home care setting. Among the all end users, the home care is expected to grow at fastest rate in the point of care/rapid diagnostic market. Industry Dynamics Growth Drivers The mounting occurrence of infectious diseases, budding government support, mounting occurrence of target diseases, technological improvements and innovative product launches and boosting use of home-based POC devices are the primary growth drivers for point of care/rapid diagnostic market. In addition, mounting amount of regulatory sanctions for innovative immunoassay techniques, expanding amount of clia-waived POC tests and lack of trained laboratory technicians are also driving the growth of the market. Healthcare decentralization, expanding number of conferences and events and POC tests with multiplexing competences are also facilitating the growth for the point of care/rapid diagnostic market. Challenges The product recalls, expanding development period for product launches, limited reimbursements, and strict and time exhausting regulatory policies are the major challenges for the growth of point of care/rapid diagnostic market. In addition, lack of alignment with definitive central lab methods, elevated price of devices, insufficient expertise about the usage of POC devices in professional settings and disinclination towards altering existing diagnostic practices are some of the factors hindering the growth of the market. Industry Ecosystem Globally, the manufacturing companies trying to enter the point of care/rapid diagnostic market are required to maintain stringent regulatory standards. Moreover, the high level of capital requirement also poses a major barrier for the entry of new players. This offers an edge to the established players in the industry competition. Geographic Overview Geographically, North America is the largest point of care/rapid diagnostic market as in the region the occurrence of lifestyle associated diseases is increasing. Mounting number of product approvals and expanding government schemes are also up surging growth of the North American point of care/rapid diagnostic market. Asia-Pacific is observed to witness fastest growth in the market, as the region comprises of large population base. In addition, mounting occurrence of lifestyle associated diseases, budding government initiatives, and escalating occurrence of infectious disease are also creating a positive impact on the point of care/rapid diagnostic market growth in the region. Competitive Insight Key players in the point of care/rapid diagnostic market are catering the demand of these devices by investing on technologically advanced products in their product portfolio across the globe. In June 2018, Abbott received FDA clearance for the Afinion HbA1c diagnostic assay for identifying patients at risk of diabetes and diagnosing diabetes. Abbott Laboratories, Danaher Corporation, Accubiotech, Johnson & Johnson, Becton, Dickinson, and Company, EKF Diagnostics, Nova Biomedical, Quidel, Roche Diagnostics, Chembio Diagnostics, PTS Diagnostics and Instrumentation Laboratory are the key players offering point of care/rapid diagnostic.

Tvynzresearch

Download Presentation

Global Point of Care/Rapid Diagnostic Market – Analysis and Forecast (2018-2024)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

Point of Care/Rapid Diagnostic Market
About VynZ Research… • VynZ Research is a global market research firm offering research, analytics, and consulting services on business strategies. We have a recognized trajectory record and our research database is used by many renowned companies and institutions in the world to strategize and revolutionize business opportunities. The company focuses on providing valuable insights on various technology verticals such as Chemicals, Automotive, Transportation, Energy, Consumer Durables, Healthcare, ICT and other emerging technologies. • VynZ Research has one of the most qualified & experienced analysts, who are constantly tracking the markets and the technologies. The research team has years of proven experience and wide knowledge & understanding of the technology, application, business models, and regulators of the segments and the value chain involved. • A trusted & proven methodology that involves highest quality of primary research, secondary analysis collated & verified through various sources including cross checking with different industry experts. • Serving wide range of customers most of them from Fortune 2000 companies • With a dedicated 24x7 customer helpline our customers can reach for specifying their needs • Developing long term relationship with the clients and satisfying them is one of the crucial notches of the company. VynZ Research aims at gaining and retaining its clients in order to make long term customer relationship.
Point of Care/Rapid Diagnostic Market Point of care diagnostic allows diagnoses in the remote setting, home, physician’s office, or in the hospital. The outcomes of diagnosis are rapid, and allow speedy treatment to the patient. The global point of care/rapid diagnostic market is growing at significant rate, due to mounting occurrence of infectious diseases and technological improvements and innovative product launches. Different products contributed to the point of care/rapid diagnostic market size.
Point of Care/Rapid Diagnostic Market The mounting occurrence of infectious diseases, budding government support, mounting occurrence of target diseases, technological improvements and innovative product launches and boosting use of home-based POC devices are the primary growth drivers for point of care/rapid diagnostic market. In addition, mounting amount of regulatory sanctions for innovative immunoassay techniques, expanding amount of clia-waived POC tests and lack of trained laboratory technicians are also driving the growth of the market. Healthcare decentralization, expanding number of conferences and events and POC tests with multiplexing competences are also facilitating the growth for the point of care/rapid diagnostic market.
Point of Care/Rapid Diagnostic Market Asia-Pacific is observed to witness fastest growth in the market, as the region comprises of large population base. In addition, mounting occurrence of lifestyle associated diseases, budding government initiatives, and escalating occurrence of infectious disease are also creating a positive impact on the point of care/rapid diagnostic market growth in the region. Abbott Laboratories, Danaher Corporation, Accubiotech, Johnson & Johnson, Becton, Dickinson, and Company, EKF Diagnostics, Nova Biomedical, Quidel, Roche Diagnostics, Chembio Diagnostics, PTS Diagnostics and Instrumentation Laboratory are the key players offering point of care/rapid diagnostic.
For Sample Report :- https://www.vynzresearch.com/healthcare/point-of-carerapid-diagnostic-market/request-sample www.vynzresearch.com

Global Point-Of-Care Diagnostics Market Forecast to 2024

The “Global Point-of-Care Diagnostics Market” is estimated to witness a CAGR of 7.7% during the forecast period 2018–2024. The market is analyzed based on four segments –products, prescription mode, end-users and regions.

107 views • 9 slides

Global Electric Motor Market – Analysis and Forecast (2018 – 2024)

The global electric motor market is expected to grow at a CAGR of 5.9% with its market size attaining a value of USD 145.3 billion by 2024. Electric motors are electro-automated procedures that perform operations on the basis of electromagnetic induction since they are extensively efficient and durable. Furthermore, these devices entail low maintenance, have high resolution for shifting voltages. The growth of electric motor market is attributed towards low cost of electric motors as compared to that of fossil-fuel engine as a result of which these systems are witnessing greater utilization in varied industry domains such as oil & gas and automotive domain.

79 views • 6 slides

Global Advanced Wound Care Market – Analysis and Forecast (2018-2024)

The global advanced wound care market is predicted to grow at 6.0% CAGR during the forecast period with the market size reaching USD 16.0 billion by 2024. Advanced wound care products are used for the treatment of chronic and acute wounds. These products manage wound effectively and enable faster healing. Different products such as advanced, wound therapy device and active wound care products are majorly contributing to the advanced wound care market size.

84 views • 7 slides

Global Autoinjectors Market – Analysis and Forecast (2018-2024)

The global autoinjectors market is anticipated to grow at a CAGR of 16.9% during the forecast period with its market size reaching USD 4.5 billion by 2024. The market is growing at a significant rate due to mounting occurrence chronic and lifestyle associated diseases, escalating occurrence of anaphylaxis, and advancement in technology. Autoinjectors is a small device designed to deliver a specific dose of a particular drug. These are usually spring-loaded syringes that are mainly invented for comfortable and safe dispensation of the drugs.

82 views • 7 slides

Global Beauty Devices Market – Analysis and Forecast (2018-2024)

Beauty devices are instruments or apparatus used for cosmetic purposes for the physical enhancement of its customers. The global beauty devices market was valued at USD 33.2 billion in 2017. Several devices such as cellulite reduction devices, hair removal devices, acne devices, cleansing devices, light/led therapy and photo rejuvenation devices, hair growth devices, oxygen and steamer devices, skin dermal rollers, contributes to the beauty devices market size. The significant growth in the beauty devices industry is imputed to the rise in prevalence of skin disorders, increasing rate of hormonal imbalance cases, increase in the geriatric population, and growing awareness for beauty devices.

88 views • 7 slides

Global Intraoperative Imaging Market - Analysis and Forecast (2018-2024)

Industry Insights by Product (Mobile C-Arms, Intraoperative Computed Tomography, Intraoperative Magnetic Resonance Imaging, and Intraoperative Ultrasound), Application (Neurosurgery, Orthopedic & Trauma Surgery, Spine Surgery, Cardiovascular Surgery, and Other Applications), and by End User (Hospital, and Ambulatory Surgical Centers (ASCs))

90 views • 7 slides

Global Protein Expression Market – Analysis and Forecast (2018-2024)

Industry Insights by Product & Services (Expression Vectors, Competent Cells, Reagents, Instruments, Services), by Systems (Prokaryotic Expression Systems, Yeast Expression Systems, Mammalian Cell Expression Systems, , Algal-Based Expression Systems Insect Cell Expression Systems, Cell-Free Expression Systems), by Application (Therapeutics, Research, Industrial), by End-User (Academic Research Institutes, Contract Research Organizations, Pharmaceutical And Biotechnology Companies, Others)

80 views • 7 slides

Global Scar Treatment Market – Analysis and Forecast (2018-2024)

The scar is a natural process of healing after an injury. There are different types of scars such as contracture scars, hypertrophic scars, acne scars, and keloid scars. The scar is treated with the help of over the counter drugs, injections, and surgical removal.

85 views • 7 slides

Global Skincare Devices Market – Analysis and Forecast (2018-2024)

Skincare devices are used for the diagnosis and treatment of skin ailments. Global skincare devices market was valued at USD 8.2 billion in 2017. Different types of diagnostic and treatment devices contributed to the skincare devices market size. The market has witnessed high demand for diagnostic devices for skin diseases over the last few years due to the increasing awareness regarding the diagnosis of skin ailments.

88 views • 7 slides

Global Wound Dressing Market – Analysis and Forecast (2018-2024)

The global wound dressing market is predicted to grow at 5.7% CAGR during the forecast period with the market size reaching USD 14.3 billion by 2024. Chronic wound imposes a burden on an individual and the healthcare system. Wound healing is a complex process which requires a suitable environment to promote the healing process. Wound dressing helps to heal the wound and prevent issues such as complications or infection.

91 views • 7 slides

Global Acute Care Diagnostic System Market Analysis 2013-2018 and Forecast 2019-2024

The research study, titled u201cGlobal Acute Care Diagnostic System Market Research Report 2019,u201d evaluates the historical performance and the current status of this market for a detailed understanding, emphasizing especially on the dynamics of the demand and supply of Acute Care Diagnostic System in 2019. Read more :https://www.acquiremarketresearch.com/industry-reports/acute-care-diagnostic-system-market/23423/

43 views • 3 slides

Global Compressor Market – Analysis and Forecast (2018-2024)

The global compressor market is expected to reach USD 47.9 billion by 2024, growing at a CAGR of 3.6% during the forecast period.

83 views • 7 slides

Global Automotive Sensor Market – Analysis and Forecast (2018-2024)

The global automotive sensor market is expected to reach USD 42.0 billion by 2024, growing at a CAGR of 7.0% during the forecast period. The market is growing at a remarkable rate with rise in vehicle production, growing inclination towards automated vehicle, and several government initiatives towards safety and security vehicle. Further, there is increase in number of sensors deployment in vehicle with the concern towards safety and comfort. Among the vehicle type segment, passenger cars being the largest in terms of volume contribute major share to the market. This as a result will boost the demand for automotive sensor in the vehicle sector.

83 views • 7 slides

Global Adhesion Barrier Market – Analysis and Forecast (2018-2024)

Adhesion barrier is used to reduce the risk of internal adhesion formulation after the surgery. The global adhesion barrier market is growing at a significant rate, due to expanding geriatric population and surge in a number of surgeries. Different product contributed to the adhesion barrier market size. The market has witnessed high demand for synthetic adhesion barrier in the coming years due to its benefits such as bioabsorbable properties and cost-effectiveness, a huge amount of commercially accessible synthetic adhesion barriers and greater consumption of adhesion barrier by surgeons in several surgeries. Market Segmentation Insight by Product On the basis of product, the adhesion barrier market is subdivided into natural adhesion barriers and synthetic adhesion barriers. Of both products, synthetic adhesion barriers segment accounted the largest share and is expected to grow at the fastest rate in the adhesion barrier market, due to its benefits such as bioabsorbable properties, biocompatible, and cost-effectiveness, a huge amount of commercially accessible synthetic adhesion barriers and greater consumption of adhesion barrier by surgeons in several surgeries. The natural adhesion barriers are further subdivided into fibrin and collagen & protein. In addition, synthetic adhesion barriers are further subdivided into hyaluronic acid, polyethylene glycol, regenerated cellulose, and other synthetic adhesion barriers Insight by Formulation On the basis of formulation, the market is subdivided into film formulations, gel formulations, and liquid formulations. Escalating number of surgeries, clinical confirmation defending the safety and efficiency of these forms, and greater implementation of film form adhesion barrier by surgeons due to low cost are some of the factors responsible for the growth of the film formulation. Of all the formulation, the film formulation accounted foremost share in the adhesion barrier market. Insight by Application On the basis of application, the market is subdivided into gynecological surgeries, neurological surgeries, reconstructive surgeries, cardiovascular surgeries, urological surgeries, general/abdominal surgeries, orthopedic surgeries, and other surgeries. The mounting number of C-section, pelvic cancer, and hysterectomy surgeries, intensifying occurrence of conditions such as infertility and incontinence, and escalating implementation of film-form and gel-form adhesion barriers for open and laparoscopic gynecological surgeries are the factors growing the demand of gynecological surgeries application. Among all applications, the gynecological surgeries application accounted the largest share in the adhesion barrier market. Industry Dynamics Growth Drivers Expanding the geriatric population, mounting alertness about the medical inference of post-surgical adhesion formulation, and a surge in the number of surgeries and sport-related injuries are the primary growth drivers for the adhesion barrier market. For instance, according to the World Health Organization (WHO), globally in 2010 approximately 524 million people were aged 65 years and older and is expected to reach 1.5 billion in 2050. The mounting occurrence of chronic diseases owing to geriatric population, escalating and epidemiological shift from infectious to chronic diseases are also facilitating the growth for the adhesion barrier market. Owing to the mounting occurrence of chronic disease has resulted in the number of surgeries performed globally, which damages the tissues due to surgical trauma. The adhesion barriers are used in several surgical procedures to separate internal tissue and organ during the healing process. Challenges Disinclination regarding the usage of adhesion barriers amongst surgeons and strict regulations resultant in inadequate technological innovations are the major challenges for the growth of the adhesion barrier market. Industry Ecosystem Globally, the manufacturing companies trying to enter the adhesion barrier industry are required to maintain stringent regulatory standards. Moreover, the high level of capital requirement also poses a major barrier to the entry of new players. This offers an edge to the established players in the industry competition. Geographic Overview Geographically, North America is the largest adhesion barrier market as in the region the geriatric population is increasing. In addition, the mounting occurrence of chronic diseases, mounting healthcare expenditure, the surge in a number of surgical procedure, escalating number of soft tissue injuries, and firm healthcare services are also up surging growth of the North American adhesion barrier market. For instance, according to the U.S. Census Bureau, in 2012 approximately 43.1 million people were aged 65 years and older in the U.S. and is expected to reach 83.7 million in 2050. Asia-Pacific is observed to witness the fastest growth in the market, due to mounting healthcare expenditure. In addition, a mounting number of surgeries, and escalating medical tourism are also creating a positive impact on the adhesion barrier market growth in the region. Competitive Insight Key players in the adhesion barrier industry are catering to the demand of these devices by investing in technologically advanced products in their product portfolio across the globe. In October 2018, FzioMed, Inc. launched Oxiplex/IU in the European Union for intrauterine surgery to improve surgical outcomes by decreasing post-surgical adhesions. Johnson & Johnson, C. R. Bard, Inc., FzioMed, Inc., Sanofi, Anika Therapeutics, Baxter International, Inc., MAST Biosurgery, Integra LifeSciences Holdings Corporation, Getinge Group, and Betatech Medical are the key players offering adhesion barrier.

84 views • 6 slides

Global Sterility Testing Market – Analysis and Forecast (2018-2024)

Sterility testing is performed for the occurrence or lack of feasible microorganisms skilled of escalating and growing under favorable conditions. It is used to guarantee the lack of impurities in biologics and medical devices. The global sterility testing market is growing at a significant rate due to the evolution of pharmaceutical & biotechnology companies, a mounting number of drug introductions. Different products such as instruments, kits & reagents, and services contributed to the sterility testing market size. The market has witnessed high demand for kits & reagents in the coming years due to a mounting inclination for kit-based testing and requirement of the frequent consumption of these products. Market Segmentation Insight by Product On the basis of product, the market is subdivided into instruments, kits & reagents, and services. Of all products, kits & reagents segment accounted the largest share in the market, due to the requirement of the frequent consumption of these products, the mounting contribution of the Institute for research and development activity, effortless product affordability, and escalating inclination for kit-based testing. Moreover, strict regulation of cGMP and cGLP and escalating reports of drug-related adverse events in regard to product contamination are also facilitating the growth of the kits & reagents segment in the market. In addition, the instrument segment is the fastest growing segment in the market, due to technological development in the membrane filtration device and design proposing essential features such as energy consumption, and extremely effectual at the low-pressure drop. Insight by Test On the basis of the test, the market is subdivided into membrane filtration, direct inoculation, and others. Speedy progress in the pharmaceutical and biotechnology industry, mounting filtration efficiency, and technological improvement in membrane filtration design and operations are the major factors responsible for the growth of the membrane filtration. Of all the tests, the membrane filtration accounted foremost share in the sterility testing market. Moreover, the direct inoculation segment is expected to grow at fastest rate in the market due to its use in execution of sterility testing of products which are not filterable or deformable and smaller volumes of test items can be used. Insight by Application On the basis of application, the market is subdivided into pharmaceutical and biological manufacturing, medical device manufacturing, and others. Speedy progress in the pharmaceutical and biotechnology industry is the factor responsible for the growth of the pharmaceutical and biological manufacturing application. Among all applications, the pharmaceutical and biological manufacturing application accounted the largest share in the sterility testing market. Industry Dynamics Growth Drivers Evolution of pharmaceutical & biotechnology companies, a mounting number of drug introductions, escalating occurrence of chronic diseases, government assistance for pharmaceutical and biotechnology industries, and expanding research and development assets in life sciences are the primary growth drivers for sterility testing market. For instance, according to the Centers for Disease Control and Prevention (CDC) in 2012, approximately 117 million people in the U.S. had one or the more chronic conditions. Mounting pharmaceutical outsourcing, intensifying healthcare expenditure, and technological improvement in rapid sterility test are also facilitating the growth for the sterility testing market. Challenges Strict regulatory frameworks, time exhausting sanction processes, and scarcity of expert professionals are the major challenges for the growth of sterility testing market. Industry Ecosystem Globally, the manufacturing companies trying to enter the sterility testing market are required to maintain stringent regulatory standards. Moreover, the high level of capital requirement also poses a major barrier to the entry of new players. This offers an edge to the established players in the industry competition. Geographic Overview Geographically, North America is the largest sterility testing market as in the region the new biopharmaceutical companies are established, and pharmaceutical and biotechnology industries occupied in vigorous research and development activities. In addition, intensifying need for sterility testing, mounting healthcare expenditure, the presence of active healthcare system, and primary acceptance for advanced technology are also up surging growth of the North American sterility testing market. Asia-Pacific is observed to witness the fastest growth in the market, due to mounting expenditure on life science research, and growing biopharmaceutical manufacturers. In addition, intensifying occurrence of chronic diseases, a supportive regulatory environment, and the budding inclination of pharmaceutical outsourcing are also creating a positive impact on the sterility testing market growth in the region. Competitive Insight Key players in the sterility testing market are catering to the demand of these devices by investing in technologically advanced products in their product portfolio across the globe. Merck KGaA, SGS S.A, Pacific Biolabs, Thermo Fisher Scientific Inc., Charles River Laboratories International, Inc., Sartorius AG, Biomu00e9rieux SA, and Wuxi Apptec are the key players offering sterility testing products.

74 views • 6 slides

Global Sterilization Services Market – Analysis and Forecast (2018-2024)

Sterilization is the method of abolishing all microorganisms and their pathogenic products. The global sterilization services market is growing at significant rate, due to mounting emphasis on outsourcing of sterilization processes among medical device manufacturers and escalating occurrence of hospital-acquired infections. Different types of sterilization services contributed to the sterilization services market size. The market is expected to witness high demand for contract sterilization services due to budding inclinations for contract sterilization by medical device. Market Segmentation Insight by Method On the basis of method the market is subdivided into ethylene oxide (ETO) sterilization, steam sterilization, gamma sterilization, electron beam radiation sterilization and others. Of all methods, ethylene oxide sterilization market accounted largest share in the market due to its widespread usage in numerous applications, such as food testing, sterilization and disinfection in the life sciences industry, medical device sterilization, and pharmaceutical sterilization. In addition it has various benefits such as high material compatibility, diffusion competences, and low prices related with the usage of ETO sterilization method. Insight by Type There are two types of sterilization, sterilization validation services and contract sterilization services. Budding inclinations for contract sterilization by therapeutic device companies and mounting outsourcing of sterilized dispensation by hospitals to specialized third-party vendors in order to decrease in-house prices associated to sterilization are some of the factors responsible for the growth of the contract sterilization services segment. Of both the types, the contract sterilization services are expected to grow at fastest rate in the sterilization services market. Insight by Mode of Delivery There are two modes of delivery, offsite sterilization services and onsite sterilization services. Inadequate availability of area in in-house sterile processing departments, larger output with minimal monetary threat, improved competence of contract sterilization process than in-house sterilization, and the price decline advantages offered by offsite sterilization services are the factors growing the demand of offsite sterilization services. Among the all mode of deliveries, the offsite sterilization services are expected to grow at fastest rate in the sterilization services market. Insight by End User The different end users are medical device companies, pharmaceutical & biotechnology industry, hospitals and clinics and others. Escalating number of medical device companies in developing countries, mounting usage of single-use products and mounting requirement to confirm sterility are the factors growing the demand of sterilization services in medical device companies. Among the all end users, the medical device companies accounted the largest share in the sterilization services market. Industry Dynamics Industry Trends Mounting implementation of sterilization using nitrogen oxide and budding number of acquisitions and agreements are the trends in the sterilization services market. For instance, in March 2018 Cantel Medical Corporation acquired Aexis Medical BVBA to improve its position in infection prevention market and to improve its product portfolio by access into healthcare information analytics. Growth Drivers Mounting emphasis on outsourcing of sterilization processes among medical device manufacturers, pharmaceutical companies, and hospitals, budding number of surgical procedures, escalating occurrence of hospital-acquired infections and expanding emphasis on food sterilization and disinfection in food industry are the primary growth drivers for sterilization services market. Development in the medical devices market, mounting need for e-beam sterilization, strict assessment of medical devices by FDA and mounting demand of services in developing countries are also facilitating the growth for the sterilization services market. Challenges The injurious causes of ethylene oxide and sterilization of innovative medical instruments are the major challenges for the growth of sterilization services market. Industry Ecosystem Globally, the manufacturing companies trying to enter the sterilization services market are required to maintain stringent regulatory standards. Moreover, the high level of capital requirement also poses a major barrier for the entry of new players. This offers an edge to the established players in the industry competition. Geographic Overview Geographically, North America is the largest sterilization services market as in the region the occurrence of hospital acquired infections is increasing. Mounting outsourcing of sterilization services by hospitals and medical devices companies, mounting guidelines for the usage of sterilized medical devices, and escalating number of surgeries executed in the U.S., are also up surging growth of the North American sterilization services market. Asia-Pacific is observed to witness fastest growth in the market, due to refined healthcare infrastructure. In addition, expending medical tourism, mounting occurrence of nosocomial infections, and expanding medical device and pharmaceutical industry are also creating a positive impact on the sterilization services market growth in the region. Competitive Insight Key players in the sterilization services market are catering the demand of these devices by investing on technologically advanced products in their product portfolio across the globe. For instance, in April 2018 Cantel Medical Corporation received U.S. Food and Drug Administration 510 (k) clearance for ADVANTAGE PLUS Pass-Thru automated endoscope reprocessor in order to confirm the quality in infection inhibition by decreasing the threat of human error. Steris, Johnson & Johnson, E-Beam Services, Life Science Outsourcing, Cantel Medical Corporation, Beta-Gamma-Service, Medistri, Sterigenics International, Cretex Companies, Noxilizer and Stryker are the key players offering sterilization services.

77 views • 6 slides

Global Vascular Patches Market – Analysis and Forecast (2018-2024)

Patches are covering applied to protect a wound or sore. Vascular patches are elastic material ensures minimal suture hole, bleeding and compliance. The global vascular patches market is growing at significant rate, due to mounting occurrence vascular diseases and mounting acceptance of biological patches. Different materials contributed to the vascular patches market size. The market has witnessed high demand for biologic patches in the coming years due to benefits of biologic patches such as easiness of usage, and decreased rate of infection. Market Segmentation Insight by Material On the basis of material the vascular patches market is subdivided into synthetic patches and biologic patches. Of all materials, biologic patches segment accounted the largest share and is expected to grow at fastest rate in the market due to large number of patients and benefits of biologic patches such as easiness of usage, greater biocompatibility, minimal suture line bleeding and decreased rate of infection. Insight by Application On the basis of application the market is subdivided into open repair of abdominal aortic aneurysms, vascular bypass surgery, carotid endarterectomy, and others. Elevated number of carotid endarterectomy surgeries conducted globally is the factor growing the demand of carotid endarterectomy segment. Among the all applications, the carotid endarterectomy accounted the largest share in the vascular patches market. Carotid endarterectomy is a surgical procedure to clean or open the carotid artery in order to prevent stroke. It is mainly done for people whose artery is blocked more than 50 percent. Insight by End User The different end users of the market are ambulatory surgical centers and hospitals and clinics. Accessibility of skilled professionals, convenience of infrastructure and refining healthcare infrastructure in developing countries are the factors growing the demand of vascular patches in hospitals and clinics. Among the all end users, the hospitals and clinics accounted the largest share and is expected to grow at fastest rate in the vascular patches market. Industry Dynamics Growth Drivers Mounting occurrence of vascular diseases, and escalating number of vascular surgeries performed are the primary growth drivers for vascular patches market. Abdominal aortic aneurysm, carotid artery disease and peripheral artery disease are the major vascular diseases. According to Society of Vascular Surgery, 80 percent of strokes are usually due to blockages in the carotid arteries. In addition, mounting acceptance of biological patches is also driving the growth of the market. The biological patches are biocompatible and are exceptionally tensile. It does not require special sutures and is similar to autologous tissue. Expanding geriatric population and mounting healthcare spending and refining healthcare infrastructure in developing economies are also facilitating the growth for the vascular patches market. For instance, according to World Health Organization (WHO), globally in 2010 approximately 524 million people were aged 65 years and older, and is expected to reach 1.5 billion in 2050. Challenges Demand for trained professionals, reducing number of carotid endarterectomy surgeries and product failures and recalls are the major challenges for the growth of vascular patches market. Industry Ecosystem Globally, the high level of capital requirement for companies trying to enter the vascular patches market poses a major barrier for the entry of new players. Moreover, the stringent regulatory requirements are also posing barrier for the new players. This offers an edge to the established players in the industry competition. Geographic Overview Geographically, North America is the largest vascular patches market as in the region the geriatric population is increasing. For instance, according to the U.S. Census Bureau, in 2012 approximately 43.1 million people were aged 65 years and older in the U.S. and is expected to reach 83.7 million in 2050. Mounting occurrence of vascular diseases, and mounting acceptance of biological patches are also up surging growth of the North American vascular patches market. Asia-Pacific is observed to witness fastest growth in the market, due to large pool of patients. In addition, expanding geriatric population, mounting alertness regarding advanced vascular products, refining healthcare infrastructure and mounting healthcare expenditure are also creating a positive impact on the vascular patches market growth in the region. Competitive Insight Key players in the vascular patches market are catering the demand of these devices by investing on technologically advanced products in their product portfolio across the globe. In November 2016, LeMaitre Vascular, Inc. acquired Restore Flow Allografts, LLC, to improve its biologic product range. In January 2017, Terumo Corporation acquired certain assets of Abbott and St Jude Medical of vascular closure business, to support efficient and safe intervention procedure. LeMaitre Vascular, C. R. Bard, Terumo Corporation, Baxter International, Admedus, Edwards Lifesciences, Maquet, Edwards Lifesciences, W. L. Gore & Associates, Labcor, B.Braun, and Cryolife are the key players offering vascular patches.

88 views • 6 slides

Global Pyrogen Testing Market – Analysis and Forecast (2018-2024)

Pyrogen testing is the compulsory phase in the manufacturing process to eliminate or deactivate probable bacterial contaminants. Its products are used for the treatment and diagnostic purposes. The global pyrogen testing market is growing at a significant rate, due to speedy growth in pharmaceutical and biotechnology industries and mounting number of novel drug launches. Different products contributed to the pyrogen testing market size. The market has witnessed high demand for kits and reagents in the coming years due to mounting implementation of kit-based testing and recurrence purchase of kits and reagents as compared to instruments. Download Free Report Sample At: https://www.vynzresearch.com/healthcare/pyrogen-testing-market/request-sample On the basis of test type the market is subdivided into LAL (Limulus Amebocyte Lysate) tests, rabbit tests, and in vitro tests. Benefits such as speed, more cost effective, accuracy, necessity of slight amount of the tested sample and permits detection of lower level of endotoxins, ease of handling, and flexibility in life science research are some of the factors growing the demand of LAL test. Among the all test types, the LAL test accounted the largest share and is expected to grow at fastest rate in the pyrogen testing market. The LAL tests are further subdivided into turbidimetric tests, chromogenic tests and gel clot tests. Globally, the manufacturing companies trying to enter the pyrogen testing market are required to maintain stringent regulatory standards. Moreover, the high level of capital requirement also poses a major barrier for the entry of new players. This offers an edge to the established players in the industry competition. Asia-Pacific is observed to witness fastest growth in the market, due to mounting research and development of novel drugs. In addition, mounting occurrence of chronic diseases, and mounting healthcare expenditure are also creating a positive impact on the pyrogen testing market growth in the region. Read More: https://www.vynzresearch.com/healthcare/pyrogen-testing-market Key players in the pyrogen testing market are catering the demand of these devices by investing on technologically advanced products in their product portfolio across the globe. In March 2018, Associates of Cape Cod, Inc., introduced a new, swift endotoxin recognition kit, Pyrosate, an easy-to-use Limulus Amebocyte Lysate (LAL) gel-clot test which enables rapid testing. Associates of Cape Cod, Inc., Merck KGaA, Thermo Fisher Scientific, Inc., GenScript, Charles River Laboratories, Inc., Ellab A/S, Lonza Group, and WUXI Pharmatech (Cayman) Inc. are the key players offering pyrogen testing. Audio Source: www.bensound.com About VynZ research VynZ Research is a global market research firm offering research, analytics, and consulting services on business strategies. We have a recognized trajectory record and our research database is used by many renowned companies and institutions in the world to strategize and revolutionize business opportunities. The company focuses on providing valuable insights on various technology verticals such as Chemicals, Automotive, Transportation, Energy, Consumer Durables, Healthcare, ICT and other emerging technologies. Contact Manager: Client Care Toll-Free: 18882533960 Email: kundan@vynzresearch.com Website: www.vynzresearch.com

73 views • 6 slides

Global Biosurgery Market – Analysis and Forecast (2018-2024)

Biosurgery is the combination of techniques and surgical techniques to decrease post and intra-operative complications. The global biosurgery market is growing at significant rate, due to expanding geriatric population and mounting number of surgeries. Different product and services contributed to the biosurgery market size. The market has witnessed high demand for bone-graft substitutes in the coming years due to mounting usage of bone-graft substitutes in various types of orthopedic surgeries as they decrease surgical time. Biosurgery Market Highlights Market Segmentation Insight by Product On the basis of product the market is subdivided into soft-tissue attachment, adhesion barriers, bone-graft substitutes, surgical sealants and adhesives, hemostatic agents, and staple-line reinforcement agents. Of all products, bone-graft substitutes segment accounted the largest share in the market due to the mounting usage of bone-graft substitutes in various types of orthopedic surgeries as they decrease surgical time. In addition, surgical sealants segment is expected to grow at fastest rate in the market due to mounting adoption of biosurgery products owing to its efficiency in blood loss management and easiness to use. Insight by Application On the basis of application the market is subdivided into cardiovascular surgery, orthopedic surgery, urological surgery, reconstructive surgery, general surgery, thoracic surgery, neurological surgery and gynecological surgery. Huge number of orthopedic bone and soft tissue repair surgeries and mounting occurrence of orthopedic surgeries are the factors growing the demand of orthopedic surgery application. Among the all applications, the orthopedic surgery accounted the largest share in the biosurgery market. Industry Dynamics Industry Trends Mounting market consolidation, mounting need for dental bone-graft substitutes, escalating emphasis on product launches and improvements, and mounting inclination for gelatin-based adhesives & hydrogels in surgical procedures are the trends in the biosurgery market. Growth Drivers Mounting number of surgeries, mounting prevalence of severe trauma injuries, escalating sports related injuries and robust emphasis on R&D for the launch of novel and innovative products are the primary growth drivers for biosurgery market. For instance, according to American Society of Plastic Surgeons in 2015 approximately 15.9 million cosmetic procedures were performed in the U.S., a two percent increase over 2014. In addition, mounting occurrence of chronic and lifestyle associated diseases is also driving the growth of the market. For instance, according to GLOBOCAN globally approximately 14.1 million new cancer cases were diagnosed and there were 8.2 million cancer deaths in 2012. In addition, according to World Health Organization (WHO), globally in 2015 approximately 8.8 million people died due to cancer. Moreover, approximately 70% of the deaths from cancer occur in low and middle income countries. Expanding geriatric population, mounting need for effectual blood loss management and mounting healthcare expenditure are also facilitating the growth for the biosurgery market. For instance, according to WHO, globally in 2010 approximately 524 million people were aged 65 years and older, and is expected to reach 1.5 billion in 2050. Challenges High cost of biosurgery products & escalating cost of surgical procedures, lack of skilled professionals for effectual use of biosurgery products, and strict regulatory framework are the major challenges for the growth of biosurgery market. Industry Ecosystem Globally, the manufacturing companies trying to enter the biosurgery market are required to maintain stringent regulatory standards. Moreover, the high level of capital requirement also poses a major barrier for the entry of new players. This offers an edge to the established players in the industry competition. Geographic Overview Geographically, North America is the largest biosurgery market as in the region the geriatric population is increasing. For instance, according to the U.S. Census Bureau, in 2012 approximately 43.1 million people were aged 65 years and older in the U.S. and is expected to reach 83.7 million in 2050. Mounting number of trauma injuries, mounting number of surgical procedures, mounting healthcare expenditure, mounting occurrence of chronic diseases and lifestyle associated diseases and advance technological amendment are also up surging growth of the North American biosurgery market. For instance, according to Centers for Disease Control and Prevention in 2012, approximately 117 million people in the U.S. had one or the more chronic conditions. Asia-Pacific is observed to witness fastest growth in the market, due to expanding geriatric population and refining healthcare infrastructure. In addition, mounting healthcare expenditure, mounting occurrence of chronic diseases and lifestyle associated diseases, escalating number of surgical procedures, and mounting demand for effectual blood loss management are also creating a positive impact on the biosurgery market growth in the region. Competitive Insight Key players in the biosurgery market are catering the demand of these devices by investing on technologically advanced products in their product portfolio across the globe. In April 2018, Medtronic PLC received FDA approval of Infuse Bone Graft. It is used with spine implants composed of polyetheretherketone in oblique lateral interbody fusion and anterior lumbar interbody fusion procedures. Baxter International, Inc., Medtronic, PLC., Hemostasis, LLC, B.Braun Melsungen AG, Cohera Medical Inc., C.R. Bard, Sanofi, Johnson & Johnson, Getinge Group and Integra Lifesciences Holdings Corporation are the key players offering biosurgery. About VynZ Research VynZ Research is a global market research firm offering research, analytics, and consulting services on business strategies. We have a recognized trajectory record and our research database is used by many renowned companies and institutions in the world to strategize and revolutionize business opportunities. The company focuses on providing valuable insights on various technology verticals such as Chemicals, Automotive, Transportation, Energy, Consumer Durables, Healthcare, ICT and other emerging technologies Contact Manager: Client Care Toll-Free: 18882533960 Email: kundan@vynzresearch.com Website: www.vynzresearch.com

70 views • 6 slides

Global Diagnostic Imaging Market – Analysis and Forecast (2018-2024)

Diagnostic imaging is a procedure to generate an image of internal and external body parts for clinical purpose. It has its application in several medical fields such as neurology, cardiology, orthopedics, and oncology. The global diagnostic imaging market is growing at a significant rate, due to mounting occurrence of chronic diseases and boosting number of diagnostic centers. Different product contributed to the diagnostic imaging market size. The market has witnessed a high demand for x-ray imaging systems in the coming years due to the mounting demand for mobile x-ray system, expanding the geriatric population and mounting occurrence of diseases and injuries. Market Segmentation Insight by Product On the basis of product, the diagnostic imaging market is subdivided computed tomography (CT) scanners, x-ray imaging systems, ultrasound imaging systems, nuclear imaging systems, and magnetic resonance imaging (MRI). Of all products, x-ray imaging systems segment accounted the largest share in the market, due to mounting demand for mobile x-ray system, painless and non-invasive procedure, less costly as compared to other modalities expanding the geriatric population and mounting occurrence of diseases and injuries. The CT scanners market is further subdivided into mid-slice, high-slice, and low-slice. The nuclear imaging system market is further subdivided into Spect systems and hybrid Pet systems. In addition, the x-ray imaging systems market is further subdivided on the basis of technology into digital, and analog. Moreover, the x-ray imaging market is further subdivided on the basis of portability into portable and stationary. The portable x-ray imaging segment is expected to grow at the fastest rate in the x-ray imaging system market. The ultrasound imaging system market is further subdivided on the basis of technology into 3D and 4D imaging system, 2D imaging system, and Doppler imaging. In addition, the ultrasound imaging market is further subdivided on the basis of portability into trolley based ultrasound system and compact ultrasound system. The MRI market is further subdivided into architecture into open and closed MRI systems. In addition, the MRI market is further subdivided on the basis of field strength into low to midfield MRI, ultra-high MRI and high to very high MRI. Insight by End User The different end users of the market are diagnostic imaging centers, hospitals, and others. Mounting demand for diagnostic imaging procedures and escalating number of diagnostic centers are the factors growing the demand for diagnostic imaging centers. Among all end users, the diagnostic imaging centers are expected to grow at the fastest rate in the diagnostic imaging market. Industry Dynamics Growth Drivers Expanding geriatric population, escalating funds, grants, and investments by government bodies for modernization imaging facilities, mounting demand for the diagnostic imaging procedure, technological developments in diagnostic imaging modalities, escalating alertness of early diagnosis of clinical disorders, and mounting inclination for minimally invasive treatment are the primary growth drivers for diagnostic imaging market, In addition, boosting investment from public-private organizations, refining healthcare infrastructure, mounting occurrence of chronic diseases and boosting the number of diagnostic centers are also facilitating the growth for the diagnostic imaging market. For instance, according to GLOBOCAN globally, approximately 14.1 million new cancer cases were diagnosed and there were 8.2 million cancer deaths in 2012. In addition, according to the World Health Organization (WHO), globally in 2015 approximately 8.8 million people died due to cancer. Moreover, approximately 70% of the deaths from cancer occur in low and middle-income countries. Challenges Mounting implementation of refurbished diagnostic imaging systems, lack of skilled professionals, elevated price of diagnostic imaging systems, disapproving healthcare reforms in the U.S., and technological restrictions associated with standalone systems are the major challenges for the growth of diagnostic imaging market. Industry Ecosystem Globally, the manufacturing companies trying to enter the diagnostic imaging market are required to maintain stringent regulatory standards. Moreover, the high level of capital requirement also poses a major barrier for the entry of new players. This offers an edge to the established players in the industry competition. Geographic Overview Geographically, North America is the largest diagnostic imaging market as in the region the occurrence of chronic diseases is increasing. For instance, according to GLOBOCAN in the U.S., approximately 1.6 million new cancer cases were diagnosed and there were 0.6 million cancer deaths in 2012. Expanding geriatric population, technological developments in diagnostic imaging modalities and mounting inclination for minimally invasive treatment are also up surging growth of the North American diagnostic imaging market. Asia-Pacific is observed to witness the fastest growth in the market, due to mounting occurrence of chronic diseases. In addition, expanding the geriatric population, mounting medical tourism, improving healthcare infrastructure and mounting healthcare expenditure are also creating a positive impact on the diagnostic imaging market growth in the region. Competitive Insight Key players in the diagnostic imaging market are catering to the demand of these devices by investing in technologically advanced products in their product portfolio across the globe. In February 2016, Carestream introduced digital X-ray technology that delivers rapid access to diagnostic images. Carestreamu2019s Cone Beam CT System helps physicians to assess playersu2019 injuries during the matches. It is specially designed for orthopaedic imaging. GE Healthcare, Hitachi Ltd., Siemens AG, Samsung Medison, Carestream Health, Koninklijke Philips N.V., Esaote S.P.A, Shimadzu Corporation, Toshiba Corporation, and Fujifilm Holdings Corporation are the key players offering diagnostic imaging. About VynZ Research VynZ Research is a global market research firm offering research, analytics, and consulting services on business strategies. We have a recognized trajectory record and our research database is used by many renowned companies and institutions in the world to strategize and revolutionize business opportunities. The company focuses on providing valuable insights on various technology verticals such as Chemicals, Automotive, Transportation, Energy, Consumer Durables, Healthcare, ICT and other emerging technologies Contact Manager: Client Care Toll-Free: 18882533960 Email: kundan@vynzresearch.com Website: www.vynzresearch.com

88 views • 6 slides

Global Hernia Repair Market – Analysis and Forecast (2018-2024)

Hernia is a medical condition where an organ or fatty tissue protrudes out via a weak point. Hernia repair is a surgical procedure performed for the management of a hernia. Laparoscopic repair surgery and open tension-free repair surgery are the major methods for hernia repair. The global hernia repair market is growing at significant rate, due to mounting occurrence hernia, expanding geriatric population and technological improvement. Different products contributed to the hernia repair market size. The market has witnessed high demand for mesh in the coming years due to higher cost of meshes contrasted to mesh fixators. Market Segmentation Insight by Product On the basis of product the market is subdivided into mesh and mesh fixators. Of all products, mesh segment accounted the largest share in the market, due to higher cost of meshes contrasted to mesh fixators. Hernia repair is done with the help of mesh and mesh fixator. A mesh is operated for strengthening weak spots in the muscle at the same time mending the hernia. In addition, mesh fixators are expended to repair the mesh in its place to evade displacement. The mesh segment is further subdivided into biologic and synthetic. The synthetic mesh segment accounted the largest share in the market due to low price of synthetic mesh in contrast to biologic mesh. In addition mesh fixators segment is further subdivided into track applicators, sutures, and glue applicators. The track applicator segment accounted the largest share in the mesh fixators market due to high cost of track applicators. In addition, glue applicators are expected to grow at fastest rate in the mesh fixators market. Insight by Surgery Type On the basis of surgery type the market is subdivided into femoral, inguinal, umbilical and incisional. Elevated number of inguinal surgeries performed every year is the factors responsible for the growth of the inguinal hernia. Of all the surgery type, the inguinal hernia accounted foremost share in the hernia repair market. Industry Dynamics Growth Drivers Mounting occurrence of hernia, technological improvement in the mesh material such as biological mesh, accessibility of reimbursement, mounting acceptance of mesh in repair surgeries and efficiency of mesh repair are the primary growth drivers for hernia repair market. For instance, according to a study named International Guidelines for Groin Hernia Management conducted by National Center for Biotechnology Information, in 2018, globally approximately 20 million patients undergo groin hernia repair every year. Expanding geriatric population, mounting demand for robotic surgery and mounting healthcare expenditure are also facilitating the growth for the hernia repair market. For instance, according to WHO, globally in 2010 approximately 524 million people were aged 65 years and older, and is expected to reach 1.5 billion in 2050. Challenges Elevated price of mesh repair, lack of skilled professionals, accessibility of less massive approaches and lengthy waiting period in developed countries are the major challenges for the growth of hernia repair market. In addition, complications related to hernia repair are also hindering the growth of the hernia repair market. For instance, according to FDA, pain, infection, hernia recurrence, adhesion, obstruction, bleeding, and a hole in neighboring tissues or organs are the complications related to hernia repair. Industry Ecosystem Globally, the manufacturing companies trying to enter the hernia repair market are required to maintain stringent regulatory standards. Moreover, the high level of capital requirement also poses a major barrier for the entry of new players. This offers an edge to the established players in the industry competition. Geographic Overview Geographically, North America is the largest hernia repair market as in the region the acceptance of hernia repair is increasing. In addition, expanding geriatric population, presence of large pool of hernia patients, mounting healthcare expenditure, technological improvement, and efficient and favorable healthcare system are also up surging growth of the North American hernia repair market. For instance, according to the U.S. Census Bureau, in 2012 approximately 43.1 million people were aged 65 years and older in the U.S. and is expected to reach 83.7 million in 2050. Asia-Pacific is observed to witness fastest growth in the market, due to expanding geriatric population. In addition, mounting medical tourism, improving healthcare infrastructure and mounting healthcare expenditure are also creating a positive impact on the hernia repair market growth in the region. Competitive Insight Key players in the hernia repair market are catering the demand of these devices by investing on technologically advanced products in their product portfolio across the globe. In May 2017, Integra LifeSciences Holdings Corporation launched SurgiMend MP a tissue-building solutions for complex abdominal hernia repair. In addition, in April 2017, Becton, Dickinson and Company acquired Bard, to provide innovative healthcare solutions and to improve its product portfolio. B. Braun Melsungen AG, Becton, Dickinson and Company, Getinge AB, Johnson & Johnson, Cook Group Inc., Medtronic PLC., Integra Lifesciences Holdings Corporation, W. L. Gore & Associates, Via Surgical and Herniamesh are the key players offering repair products. About VynZ Research VynZ Research is a global market research firm offering research, analytics, and consulting services on business strategies. We have a recognized trajectory record and our research database is used by many renowned companies and institutions in the world to strategize and revolutionize business opportunities. The company focuses on providing valuable insights on various technology verticals such as Chemicals, Automotive, Transportation, Energy, Consumer Durables, Healthcare, ICT and other emerging technologies Contact Manager: Client Care Toll-Free: 18882533960 Email: kundan@vynzresearch.com Website: www.vynzresearch.com

68 views • 6 slides

Global Defibrillators Market – Analysis and Forecast (2018-2024)

Defibrillator is a device used to deliver therapeutic high energy electric shock to the heart which causes depolarization of the heart muscles. It is used to treat various conditions such as cardiac arrhythmia, pulseless ventricular tachycardia and ventricular fibrillation. The global defibrillators market is growing at a significant rate, due to technological improvement, and mounting occurrence of target diseases. The market has witnessed high demand for implantable cardioverter defibrillators over the last few years due to technologically innovative devices, escalating adoption of cardiac resynchronization therapy defibrillators (CRT-Ds) and escalating occurrence of cardiovascular diseases. Market Segmentation Insight by Product On the basis of product, the defibrillators market is subdivided into implantable cardioverter defibrillators (ICDs) and external defibrillators. Implantable cardioverter defibrillators account the larger share in the market due rapid growth in the number of implant procedures, technologically advanced devices with extended longevity, integration of other technologies such as pacemaker with defibrillator, and escalating adoption of cardiac resynchronization therapy defibrillators (CRT-Ds) and subcutaneous implantable cardioverter defibrillator (S-ICD) systems across the globe. Moreover, external defibrillator is mainly used for resuscitation in case of sudden cardiac attack and stabilizes the patient until medical help arrives or patient reach the hospital. Insight by End-User On the basis of end-users the market is subdivided into hospitals, cardiac centers, and clinics, pre-hospital care settings, public access markets, home care settings and alternate care facilities. Mounting occurrences of sudden cardiac arrest, modification in guidelines by government of developed countries for making it mandatory for certain arena and escalating number of public access defibrillation programs are some of the factors responsible for the growth of the public access markets segment. Of all the end-users, the defibrillators market growth is anticipated to be the highest in public access markets. Industry Dynamics Industry Trends Growing demand for automated external defibrillators in prehospital setting, boosting pricing pressure on market players and expanding number of mergers and acquisitions among market players are the major trends observed in the defibrillators market. Growth Drivers The escalating occurrence of target diseases, mounting training and wakefulness programs on defibrillator, and mounting focus on providing public-access defibrillators are the primary growth drivers for defibrillators market. Mounting occurrence of lifestyle associated diseases such as cardiovascular diseases is fueling the growth of the market. For instance, according to the World Health Organization (WHO), globally approximately 17.7 million people died from cardiovascular diseases in 2015. Moreover, development of S-ICD and MRI-Compatible ICD & CRT-Ds, refining healthcare infrastructure in developing countries, developing healthcare infrastructure, supportive legislation guidelines and technological improvements are also fueling the demand or growth of the defibrillators market. Manufacturers are developing devices which can minimize the risk of allergy, infection and vein damage. Challenges Frequent product recall, absence of alertness about sudden cardiac arrest and problems related to the usage of implantable and mechanical external defibrillators are the major challenges for the growth of defibrillators market. Industry Ecosystem Novel product introductions and approvals were major stratagems implemented by key industry players to upsurge their market share and provide unmet requirements. In addition, globally, the manufacturing companies trying to enter the cardiac monitoring and cardiac rhythm management market are required to maintain stringent regulatory standards. Moreover, the high level of capital requirement also poses a major barrier for the entry of new players. Geographic Overview Geographically, North America is the largest defibrillators market as in the region the prevalence of cardiovascular disease is escalating. For instance, according to Centers of Disease Control and Prevention (CDC), in the U.S. approximately 610,000 people die every year due to heart disease. Moreover, according to CDC, approximately 370,000 people die annually due to coronary heart disease in the U.S. It is the most common type of heart disease in the U.S. Expanding geriatric population, mounting training and wakefulness programs, reassuring government guidelines, mounting healthcare expenditure, developed beneficial reimbursement schemes, and technological improvement and product launches are also up surging growth of the North American defibrillators market. Asia-Pacific is observed to witness fastest growth in the market, as the region comprises of large population base and mounting geriatric population. In addition, escalating occurrence of cardiovascular diseases, mounting healthcare expenditure, refining healthcare infrastructure and upsurge in medical tourism are also creating a positive impact on the defibrillators industry growth in the region. Competitive Insight Key players in the defibrillators market are catering the demand of these devices by investing on technologically advanced products in their product portfolio across the globe. In June 2018, Philips Royal launched Philips HeartStart Onsite in collaboration with Starting Hearts and medic assist. It is automated external defibrillators to create a cardiac arrest response system. In addition, in May 2018, Medtronic announced study results of exclusive AdaptivCRT algorithm associated with improved patient survival. Medtronic Plc., Cardiac Science, St. Jude Medical, Nihon Kohden, Boston Scientific, Philips, Biotronik, Zoll Medical, Physio-Control, Livanova, and Schiller are the key players offering defibrillators.

66 views • 6 slides

More Related